Home/Filings/4/0001062993-24-008111
4//SEC Filing

Bohnen Shane 4

Accession 0001062993-24-008111

CIK 0000842023other

Filed

Apr 4, 8:00 PM ET

Accepted

Apr 5, 4:53 PM ET

Size

8.1 KB

Accession

0001062993-24-008111

Insider Transaction Report

Form 4
Period: 2024-04-03
Bohnen Shane
SVP - General Counsel
Transactions
  • Exercise/Conversion

    Common Stock

    2024-04-03+2,2592,394 total
  • Tax Payment

    Common Stock

    2024-04-03$67.87/sh747$50,6991,647 total
  • Exercise/Conversion

    Restricted Stock Units

    2024-04-032,2594,519 total
    Common Stock (2,259 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
  • [F2]2,260 restricted stock units vest on 4/3/25 and 2,259 restricted stock units vest on 4/3/26.

Issuer

BIO-TECHNE Corp

CIK 0000842023

Entity typeother

Related Parties

1
  • filerCIK 0001969581

Filing Metadata

Form type
4
Filed
Apr 4, 8:00 PM ET
Accepted
Apr 5, 4:53 PM ET
Size
8.1 KB